We report the performance of a liquid chromatography (LC) assay for detection and confirmation of cocaine and cocaethylene in serum. A photodiode array (PDA) detector monitors the cyano column effluent at 230 nm for analyte detection. Confirmation of a peak's identity is performed by use of only the 226-254-nm segment of the spectra rather than a broader range such as 210-340 nm. Use of the narrower range improves the assay's sensitivity by almost 10-fold. Analyte values of 10 g/L are confirmed routinely. Intra-assay imprecision at 100, 20, and 10 1zg/L for cocaine is 5.1%, 5.7%, and 6.6% (CV), respectively. Absolute recovery of the analytes exceeds 80%. In a split-sample study (33 positives and 74 negatives), each of this method's cocaine findings were confirmed. Cocaethylene was found in 15 of these samples. A complete chromatogram can be available 15 mm after the start of the procedure. The method's focus on the active drug (rather than urinary metabolites) and its ability to detect and confirm many other drugs make it well suited for emergency toxicology testing.
system stimulant with a half-life of--i h in humans (1). From 75% to 90% of a dose is converted to the inactive metabolites ecgonine methyl ester and benzoylecgonine (1), which are excreted in the urine for several days after use of the parent drug. Immunoassays for detection of cocaine abuse are designed to detect these longerlived metabolites.
A positive urine assay for cocaine metabolites suggests cocaine use during the past few days, and does not mean the parent drug is present in the patient's blood. Cocaine use is associated with seizures, hallucinations, and arrhythmias, and the knowledge that it is present in the blood may be useful in emergency medical situations.
Use of urine metabolite assays to determine the presence of active parent drug in blood can be misleading (2), but such assays are widely used in the absence of rapid, readily available serum cocaine assays.
Detection of low concentrations of cocaine in blood samples is difficult. Peak serum concentrations of iOO-500 igfL are typical shortly after recreational use (1), but its short half-life and instability in unpreserved blood samples (3) suggest that much lower concentrations need to be detected.
The drug's volatility and susceptibility to hydrolysis (4) are potential sources of analytical error. Ideally, an assay of serum cocaine Chemistry Laboratory, Gray 5, Massachusetts General Hospital, Boston, MA 02114.
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would be rapid and able to detect other drugs seen in emergency situations. Confirmation of positive results would be desirable. Sensitive assays for serum cocaine that use gas-liquid chromatography or liquid chromatography (LC) are described in references [5] [6] [7] . A discussion of cocaine methodologies is contained in reference 1. Generally, these procedures were used for quantification of cocaine in pharmacokinetic studies or in cocainerelated postmortem overdose cases, not as rapid emergency toxicology assays. In this report we present the performance of an LC assay to detect serum cocaine that meets many of the requirements of an emergency toxicology laboratory. at 230 am (equivalent to 8-10 g/L for analyte in serum) is investigated. if the peak matches the retention time (within 0.03 mm) and ultraviolet spectra (from 226 to 254 am) for cocaine and (or) cocaethylene, it is considered positive for the analytes. If necessary, quantification is performed by using the confirmed peak's height ratio to that of the internal standard and comparing this ratio with that obtained for a working standard solution.
It is supplementary to an LC

Comparison method.
Patients' samples analyzed by this method were also tested by a modification of the reversed-phase LC procedure of Jatlow and Nadim (13). We did not use the extraction procedure cited there. Rather, 75 L of the extract remaining from the LC/ PDA procedure was injected into a chromatographic system duplicating that described previously (13) . Protriptyline served as the internal standard. This modification frequently exhibited an unidentified peak close to the retention time of cocaethylene. This interference was probably caused by the use of a different extraction procedure from that specified in reference 13. but elute close to the "solvent front" complex seen in all serum samples (see Figure 1) . We substituted phosphate buffers of pH 6.78, 7 .00, and 7.10 for the buffer specified (pH 6.90), and analyzed controls by using these mobile phases to evaluate the resolution of the analytes from interferences. Decreasing buffer pH increased both analyte retention and resolution from the solvent front. A buffer with a pH of 6.78 provided better resolution than the one specified (pH 6.90), but we chose not to evaluate it further, because it caused a later-eluting peak of interest to us (desipramine) to co-elute with the internal standard. Buffer pHs of 7.00 and 7.10 caused cocaine to elute closer to the solvent front than one of pH 6.90 . The ultraviolet spectrum of cocaine was unchanged and indistinguishable from that of cocaethylene in each of these mobile phases. Representative spectra are shown in Figure 2 .
The retention-time variability of the analytes was minimal with recycled mobile phase (see Table 1 ). All of five columns recently used adequately resolved cocaine from the serum solvent front. Cocaine was not stable in mobile phase. During an 11-day period a 500 pg/L solution stored at room temperature lost --15-20% of its cocaine. Cocaethylene appeared more stable in mobile phase. Fig. 1(d) , representIng 106 ,ug/I. of cocaethylene.
(a) is the spectrum of the broad I.8-mm interference peak shown in Fig. 1(b 
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210-340 nm (mean, CV) peak in a control to that of a standard analyte spectrum in the PDA computer library. The algorithm that computes this match has been described (14). An exact match will generate a value of 1000, and as the unknown and standard spectra differ more, the algorithm generates progressively lower numbers.
We require a value >940 to declare a match between the spectra for an unknown peak and a standard in the PDA library. five (reduced haloperidol, procaine, propiomazine, propoxyphene, and trimethobenzamide) were eluted within 0.03 mm of the analytes, but their spectra were not similar to those for the analytes.
Only four (benoxinate, norcocaine, quinine, and verapamil) of the compounds eluting between 1.4 and 2.0 mm had spectra matching those of the analytes in the 226-254-nm PDA library. Of these four, none had retention times within 0.03 mm of the analytes, and only norcocaine matched
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the analytes' spectra when the 226-300-and 210-340-nm PDA library spectra were used. Norcocaine was analyzed within 3 h of receipt. All samples were analyzed by this method, and the extract from each sample was chromatographed according to the procedure of Jatlow and Nadim (13). The LC/PDA method found 34 samples to be positive for either analyte ( library spectra (226-300 mu) were used. These samples 7-Hydroxyamoxapine
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had cocaine concentrations ranging from 6 to 38 pg/L. 8-Hydroxyamoxapine 1.64 Of these 30 cocaine-positive samples, this method Two of the remaining three cocaethylene Dibucaine
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findings by LC/PDA in the split sample study were The portion of the analytes' spectra used in the matching process greatly affected the lower concentraPropoxyphene 1.69 tion limit at which the identity of the analytes can be Protriptyline (internal standard) 5.35 confirmed (see Table 1 ). Inclusion of 210-225-nm absorQuinidine
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bance data in the matching process results in poorer data lowers the overall signal-to-noise ratio of the spectra, resulting in poorer matches.
Use of the narrow range improves the lower limit of identification, but theoretically leads to poorer assay selectivity. As an example, compounds mimicking the spectra of the analytes at 226-254 mu but differing at higher wavelengths (e.g., benoxinate, quinine, or verapamil) could be incorrectly matched to the PDA library spectra of the analytes. Such false-positive results are likely to be rare because the PDA displays the full spectrum of a peak to a user, even though only a portion of the spectrum is used in the matching algorithm. Cocaine's enantiomer and diastereoisomers have similar ultraviolet spectra (15) as the analytes but were not available for study; they should be consideredpotential interferences, but are not recognized as abused drugs.
A complete chromatogram can be available in 15 mm when this procedure is used. This assay reduces the need to perform a drug screen on both a patient's serum sample (to detect drugs other than the analytes) and a simultaneously collected urine specimen (to evaluate the presence of cocaine). Unlike cocaine metabolite assays of urine, a serum cocaine assay can provide unequivocal information regarding the presence of active drug in a patient's blood. This method's sensitivity and ability to detect many other drugs make it very useful in an emergency toxicology setting.
